subject area of
- ???Lost in Translation??? Journal Articles
- A Multinational Pharmacoeconomic Evaluation of Acute Major Depressive Disorder (MDD): a Comparison of Cost-Effectiveness Between Venlafaxine, SSRIs and TCAs Journal Articles
- A pharmacoeconomic evaluation of the myocardial ischemia reduction with aggressive cholesterol lowering (MIRACL) study in Canada. Journal Articles
- Applied pharmacoeconomics: considerations to drive the choice of a prophylactic antithrombotic regimen Journal Articles
- Better Treatments That Cost More: The Dilemma Journal Articles
- Canada's new guidelines for the economic evaluation of pharmaceuticals. Conferences
- Canadian Guidelines for Economic Evaluation of Pharmaceuticals Journal Articles
- Choices of Methodology in Pharmacoeconomic Studies Journal Articles
- Consistently Estimating Absolute Risk Difference when Translating Evidence to Jurisdictions of Interest Journal Articles
- Cost Effectiveness in Canada of a Multidrug Prepackaged Regimen (Hp-PAC??)* for Helicobacter pylori Eradication Journal Articles
- Cost-effectiveness analysis in oncology Journal Articles
- Cost-effectiveness of chemotherapy for nonsmall-cell lung cancer Journal Articles
- Cost-effectiveness to tolterodine for patients with urge incontinence who discontinue initial therapy with oxybutynin: A Canadian perspective Journal Articles
- Economic Evaluation of Ciprofloxacin Compared with Usual Antibacterial Care for the Treatment of Acute Exacerbations of Chronic Bronchitis in Patients Followed for 1 Year Journal Articles
- Estimation, Power and Sample Size Calculations for Stochastic Cost and Effectiveness Analysis Journal Articles
- Impact of reference-based pricing of nitrates on the use and costs of anti-anginal drugs. Journal Articles
- Incorporation of uncertainty in health economic modelling studies Journal Articles
- Information Barriers to the Implementation of Economic Evaluations in Japan Conferences
- Information Created to Evade Reality (ICER) Journal Articles
- Network vs. Pairwise Meta-Analyses: A Case Study of the Impact of an Evidence-Synthesis Paradigm on Value of Information Outcomes Journal Articles
- Perioperative bridging interruption with heparin for the patient receiving long-term anticoagulation Journal Articles
- Pharmacoeconomics of Systemic Therapies for Lung Cancer Journal Articles
- Pragmatic pharmacoeconomic analyses by using post-market adverse drug reaction reports: an illustration using infliximab, adalimumab, and the Canada vigilance adverse reaction database Journal Articles
- Proper preference-based outcome measures in economic evaluations of pharmaceutical interventions. Journal Articles
- Review of enoxaparin and its clinical applications in venous and arterial thromboembolism Journal Articles
- Statistical Methods for the Analysis of Discrete Choice Experiments: A Report of the ISPOR Conjoint Analysis Good Research Practices Task Force Journal Articles
- Systematic validation of disease models for pharmacoeconomic evaluations Journal Articles
- The Canadian Optimal Therapy of COPD Trial: Design, Organization and Patient Recruitment Journal Articles
- The Revised Canadian Guidelines for the Economic Evaluation of Pharmaceuticals Journal Articles
- Why Has the Use of Health Economic Evaluation in Japan Lagged Behind that in Other Developed Countries? Conferences
- Work Productivity and Healthcare Resource Utilization Outcomes for Patients on Etanercept for Moderate-to-Severe Plaque Psoriasis Journal Articles